MMP1 and colonic neoplasm: In vitro, darifenacin also appeared to suppress ACh-stimulated colon cancer cell invasion, with a corresponding suppression of MMP1 mRNA expression, presumably via inhibition of p38, ERK1/2, and Akt signaling [62].